What is Parry-Romberg syndrome / Progressive hemifacial atrophy

TL;DR: Parry-Romberg syndrome (also known as progressive hemifacial atrophy) is a rare, acquired disorder characterized by the slow, progressive shrinkage or wasting away of skin and soft tissues on one side of the face. While the exact cause remains unknown, it is considered a localized form of scleroderma that typically affects the face, skin, muscles, and occasionally underlying bony structures.

What exactly is Parry-Romberg syndrome?

Parry-Romberg syndrome is a rare, degenerative condition that results in the atrophy (wasting) of tissues beneath the skin, usually involving the fat, connective tissue, and sometimes the muscles or bones. Because it is a progressive condition, the degree of facial asymmetry can change over several years before eventually stabilizing. Within the DiseaseMaps.org community, 106 individuals have shared their experiences, highlighting the diverse ways this rare disease manifests across different ages and severities.

Which body systems are affected by progressive hemifacial atrophy?

The primary impact of Parry-Romberg syndrome is localized to the face, though it can occasionally extend to the neck or scalp. The progression typically follows a specific pattern of tissue loss:

• Dermal and Subcutaneous Tissue: The skin often becomes thin, and the underlying fat layer disappears, leading to a sunken appearance.


• Muscular System: Muscles on the affected side may weaken or shrink, which can alter facial expressions.


• Skeletal System: In some cases, particularly if the disease begins in childhood, the underlying bone growth may be stunted or altered.


• Ocular and Dental: Patients may experience secondary issues such as sunken eyes (enophthalmos) or dental complications due to changes in the jaw structure.


• Neurological System: Some individuals report associated symptoms like migraines, trigeminal neuralgia, or seizures, though these are not universal.

Who is typically affected and how common is it?

Parry-Romberg syndrome is exceptionally rare, with an unknown exact prevalence. It is more frequently diagnosed in females than in males, with a ratio of approximately 3:2. While the onset can occur at any age, the most common window for the first symptoms to appear is between 5 and 15 years of age. There is no known geographic, ethnic, or racial predilection for the condition.

What is the underlying cause of this condition?

The exact pathophysiology of Parry-Romberg syndrome is not fully understood, but current medical research suggests it may be an autoimmune process. Many experts classify it as a variant of localized scleroderma (specifically linear scleroderma "en coup de sabre"). The process involves chronic inflammation that leads to the gradual destruction of the fat pads and soft tissue of the face. Unlike genetic conditions, it is generally considered a sporadic event, meaning it is not typically passed down through families.

How does it differ from other conditions?

Differentiating Parry-Romberg syndrome from other conditions is essential for proper management. Unlike congenital facial hemihypertrophy, which is present at birth, Parry-Romberg syndrome is acquired and progressive. It is also distinct from systemic sclerosis, as it is usually limited to one side of the face and does not typically involve the internal organs of the body.

Next steps

• Consult with a specialist physician, such as a dermatologist, rheumatologist, or plastic surgeon, to confirm the diagnosis and assess the extent of tissue involvement.


• Monitor for any neurological symptoms, such as headaches or seizures, and discuss these with a neurologist.


• Join the DiseaseMaps.org community to connect with others who have been diagnosed with Parry-Romberg syndrome and share management strategies.


• Seek a referral to a craniofacial center if the condition is affecting bone structure or dental alignment.

Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Parry-Romberg syndrome profile.


• Orphanet: Progressive hemifacial atrophy (ORPHA:776).


• OMIM (Online Mendelian Inheritance in Man): Entry #141300 regarding Hemifacial Atrophy.


• PubMed: Recent clinical literature reviews on the autoimmune pathogenesis of Parry-Romberg syndrome.